Partnership Established: Memorandum of Understanding (MoU) between MOSB and the National Cancer Centre Singapore
In a significant development, the Medical Oncology Society in Bangladesh (MOSB) has signed a Memorandum of Understanding (MoU) with the National Cancer Centre Singapore on July 26, 2025. This collaboration marks a significant milestone in strengthening the partnership between Bangladesh and Singapore in the fight against lung cancer.
The MoU, aimed at advancing lung cancer management, was signed at the BRAC Centre Auditorium in Mohakhali, Dhaka. The ceremony was followed by a full-day workshop titled "Recent Updates on Evidence-Based Lung Cancer Management."
Professor Dr Parveen Shahida Akhtar, President of MOSB, addressed the workshop's commencement, highlighting that the MoU marks a significant step forward in advancing cancer treatment through mutual cooperation and knowledge exchange. The workshop was supported by the National Cancer Centre Singapore and scientific partner Renata PLC.
Dr Tan Wei Chong, a distinguished international expert from the National Cancer Centre Singapore, delivered an engaging presentation on the latest advancements in lung cancer management. His talk was followed by a lively question-and-answer session, during which physicians expressed their appreciation for Dr Tan's comprehensive and insightful discussion.
Certificates of Attendance were presented to all participating doctors, attracting both young and senior medical oncologists. The workshop, while not specified in location, is part of a broader initiative that aims for collaborative clinical trials and the development of shared training modules to enhance knowledge exchange and improve patient care.
While specific details about joint research, exchange programs, or training modules are not publicly available, the Asia-Pacific Journal of Clinical Oncology promotes multidisciplinary oncology collaboration across Asia, which could provide a platform supportive of such partnerships. The National Cancer Centre Singapore is also active in the Asia-Pacific oncology community, as seen by senior consultants like Dr. Matthew Ng speaking at regional conferences.
As more detailed information might be found on official websites of the Medical Oncology Society of Bangladesh or the National Cancer Centre Singapore, or via direct institutional communication, this partnership could pave the way for further joint research and regular exchange programs in the future.
The collaboration between the Medical Oncology Society in Bangladesh (MOSB) and the National Cancer Centre Singapore, as outlined in the signed MoU, focuses on advancing medical-conditions like lung cancer through science and health-and-wellness initiatives, such as joint clinical trials and shared training modules. The workshop titled "Recent Updates on Evidence-Based Lung Cancer Management" demonstrated this commitment, showcasing knowledge exchange and fostering discussions on the latest advancements in cancer treatment.